Showing 321 - 340 results of 64,065 for search '(( 50 ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 2 e decrease ))', query time: 1.49s Refine Results
  1. 321
  2. 322

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  3. 323

    Controlling the Temperature and Speed of the Phase Transition of VO<sub>2</sub> Microcrystals by Joonseok Yoon (1419355)

    Published 2016
    “…We investigated the control of two important parameters of vanadium dioxide (VO<sub>2</sub>) microcrystals, the phase transition temperature and speed, by varying microcrystal width. …”
  4. 324

    Decrease in number of activated macrophages in demyelinated nerves subjected to 1hr ES. by Nikki A. McLean (643606)

    Published 2014
    “…Note: ES results in a significant decrease in the ED-1 IF 10d post-LPC (5d post-ES; K) and 12d post-LPC (7d post-ES; N) relative to LPC only in a pattern suggestive of movement toward lateral edges and egress (arrow). …”
  5. 325
  6. 326
  7. 327
  8. 328
  9. 329
  10. 330

    NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

    Published 2020
    “…(J) A proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways through inversely modulating the levels of positive and negative pathway components is shown. Drk/Grb2 and MAPK, two positive components of the EGFR signaling pathway are targeted for degradation by the Arg/N-end rule pathway and E3 ubiquitin ligase Ubr4 while PP2AC, a negative regulator of EGFR signaling pathway, is targeted for degradation by the Ac/N-end rule pathway E3 ubiquitin ligase Cnot4. …”
  11. 331
  12. 332
  13. 333

    Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

    Published 2025
    “…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”
  14. 334
  15. 335
  16. 336
  17. 337

    Ab Initio Study of the Substituent Effects on the Relative Stability of the <i>E</i> and <i>Z</i> Conformers of Phenyl Esters. Stereoelectronic Effects on the Reactivity of the Car... by Helmi Neuvonen (2643793)

    Published 2005
    “…The n<sub>O</sub> → π*<sub>C</sub><sub></sub><sub>O</sub> electron donation has a minimum value with τ<sub>1</sub> = 90° and a maximum value with τ<sub>1</sub> = 0° (the <i>Z</i> conformer), the value with τ<sub>1</sub> = 180° (the <i>E</i> conformer) being between these two values, obviously due to steric hindrance. …”
  18. 338
  19. 339

    Dimerization of [Fe<sup>III</sup>(bpy)<sub>3</sub>]<sup>3+</sup> in Aqueous Solutions: Elucidating a Mechanism Based on Historical Proposals, Electrochemical Data, and Computationa... by Nicolas E. Holubowitch (9254254)

    Published 2022
    “…Despite these favorable characteristics, its oxidized Fe­(III) form undergoes dimerization to form μ-O-[Fe<sup>III</sup>(bpy)<sub>2</sub>(H<sub>2</sub>O)]<sub>2</sub><sup>4+</sup>, leading to a dramatic ∼0.7 V decrease during battery discharge. …”
  20. 340